📊 Score Breakdown
Offering Ability
60
Cash Runway
10
Float Risk
20
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
32%
📉 Score Deterioration
40%
• Score rose 24 points recently (worsening)
🔄 Reverse Split
30%
• 50-day avg $1.64 approaching $1 threshold
🔁 Convertible Conversion
15%
• Convertible debt present: 8.4% potential dilution
💹 Market Data
Market Cap$21.49M
Shares Outstanding14.42M
Float12.65M
Cash$44.38M
Debt$6.90M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 17.6% shares (2025Q4 vs prior)
21 institutional holders · 357.9K shares
#1
VANGUARD GROUP INC
104.4K shares
#2
GEODE CAPITAL MANAGEMENT, LLC
81.9K shares
#3
UBS Group AG
79.8K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.48M
Days to Cover4.3
% of Float11.7%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2024
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CYN
📊 CYN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CYN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.